Research

Three members of The Institute are among recipients of D2R funding to support their groundbreaking research on RNA-based therapies for cancer and rare...

Earlier this month, over 150 researchers from across McGill and partner institutions came together at Le Centre Sheraton for the inaugural DNA to...

Sold-out event united health researchers and innovators to shape the future of healthcare On March 24, 2025, The Institute proudly partnered with Research...

‘Our findings could help doctors and mental health professionals better educate patients about the potential risks of frequent cannabis use’  A McGill University-led...

Research confirms the use of epinephrine before arrival at the hospital significantly reduces intensive care admissions for anaphylactic reactions During a severe allergic...

Commissioned work underscores the role of tuberculosis (TB) as a leading cause of death globally, stressing the importance of early diagnosis, comprehensive care,...

Breakthrough that stands to rewrite the textbooks on brain function could lead to treatments A new study by McGill University researchers yields insights...

Oncology researcher is building partnerships with cancer agencies to empower patients and transform research   As Program Director of the Global Oncology Program in...

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians   A project led by Ziv Gan-Or, MD, PhD,...

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy Swelling caused by brain cancer is a problem that can lead to...

Despite previous concerns, findings provide reassurance about the psychiatric safety of these drugs, say researchers from the Lady Davis Institute for Medical Research...

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi,...